Healthcare101

  Breast Imaging Market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $6.6 billion by 2028, growing at a CAGR of 8.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include rising awareness campaigns, increasing public-private investments, and lucrative opportunities in emerging markets. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897 Browse in-depth TOC on "Breast Imaging Market" 244 - Tables 37 - Figures 266 – Pages Non-ionizing breast imaging technologies segment to register significant growth rate over the forecast period of 2023-2028 Based on the technology, the global breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The non-ionizing breast imaging technologies segment is anticipated to register the highest growth rate ov

 The global AI in biotechnology market is experiencing significant growth, with projections indicating an increase from USD 3.23 billion in 2024 to USD 7.75 billion by 2029. This remarkable expansion reflects a compound annual growth rate (CAGR) of 19.1% during the forecast period. This document explores the factors driving this growth, the applications of AI in biotechnology, and the implications for the industry. Market Overview The integration of artificial intelligence (AI) in biotechnology is revolutionizing the way research and development are conducted. AI technologies are being utilized to enhance drug discovery, streamline clinical trials, and improve personalized medicine, among other applications. The increasing demand for innovative solutions in healthcare and the growing volume of biological data are key factors contributing to the market’s expansion. Key Drivers of Growth Rising Demand for Personalized Medicine : The shift towards personalized medicine is driving the need

 The Halal empty capsules market is a burgeoning sector within the pharmaceutical industry. With a significant Muslim population worldwide and increasing awareness of ethical dietary restrictions, the demand for Halal-certified capsules is rapidly rising. These capsules offer a viable solution for those who adhere to Halal dietary practices while also providing options for non-Muslims who prioritize safe and ethical ingredients in their supplements and medications. This blog delves into the Halal empty capsules market, covering its growth drivers, product types, manufacturing processes, regulatory considerations, and emerging trends. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166042038 1. Understanding Halal Empty Capsules Halal empty capsules are gelatin-based or non-gelatin capsules certified as Halal, meaning they comply with Islamic dietary laws. In Halal certification, products must avoid substances derived from non-Halal animals (such

  Laboratory consumables play an essential role in scientific research, diagnostic testing, and manufacturing processes across numerous industries. From basic research and clinical testing to quality control in industrial labs, these single-use items are integral to ensuring accuracy, efficiency, and safety in laboratory environments. This article will delve into the evolving lab consumables market, exploring key trends, challenges, and future prospects. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184125947 1. Understanding the Lab Consumables Market Laboratory consumables encompass a wide array of disposable items used in laboratory procedures, including pipettes, test tubes, petri dishes, syringes, gloves, and vials. Unlike laboratory equipment, which can be reused over time, consumables are typically discarded after one use. This aspect contributes to the recurring demand for these products, making the consumables market a vital part of la

 The microbiome diagnostics market is gaining unprecedented attention as the study of the human microbiome transforms healthcare. The microbiome, a community of trillions of microorganisms in and on our bodies, plays a significant role in human health, influencing immunity, digestion, mood, and disease susceptibility. This emerging field of microbiome diagnostics, which involves assessing these microbial populations to understand and address health conditions, is becoming a vital asset in personalized medicine. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132581140 What is Microbiome Diagnostics? Microbiome diagnostics involves analyzing microbial populations in the human body to diagnose health conditions or predict disease risks. These diagnostics utilize cutting-edge sequencing and data analysis technologies to measure bacterial, viral, and fungal populations. Tests can range from gut microbiome analysis, which evaluates gastroi

 The global peritoneal dialysis market is set to grow from USD 9.58 billion in 2024 to USD 12.70 billion by 2029, reflecting a robust CAGR of 5.8%. This expansion is largely driven by the rising prevalence of chronic kidney disease (CKD), particularly among older populations, as well as a shift towards home-based treatment options. Notably, about 14% of U.S. adults are affected by CKD, with significant government support for peritoneal dialysis in countries like China, enhancing accessibility. Key players such as Baxter International, Fresenius Medical Care, and Medtronic are advancing technologies to improve patient care, yet the market faces challenges like underutilization in low-income regions and a critical shortage of skilled nephrologists. Emerging economies like India and Brazil present significant growth opportunities, especially with increased healthcare expenditure. The Asia Pacific region is anticipated to exhibit the highest growth, fueled by an aging population and enhan

 The Global Lipid Nanoparticles Market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a CAGR of 5.2%, while the LNP services market is projected to rise from USD 135.5 million in 2024 to USD 238.1 million by 2029 at a CAGR of 11.9%. Growth is driven by advancements in LNP-based pharmaceuticals, particularly in anti-cancer and mRNA therapies, though regulatory challenges and formulation issues pose potential constraints. Key opportunities include the demand for advanced drug delivery systems and scalable mRNA vaccines. The market's key players include Avanti Polar Lipids, Merck KGaA, and FUJIFILM Pharmaceuticals, with North America being the leading regional market. The sector is influenced by diverse product segments such as ionizable and PEGylated lipids, with applications spanning COVID-19 and cancer treatments. Download PDF Brochure Browse in-depth TOC on "Lipid Nanoparticles Market" 398 - Tables 53 - Figures 316 - Pages

 The global RNA analysis market growth forecasted to transform from USD 5.3 billion in 2023 to USD 9.9 billion by 2028, driven by a CAGR of 13.4%. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many peptide-based research projects are also being fostered by increasing collaborative partnerships among various companies that are driving market growth. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240344576 Browse in-depth TOC on "RNA Analysis Market" 178 - Tables 46 - Figures 263 - Pages The reagents/consumables segment accounted for the largest share of the product & service segment in the RNA analysis market in 2022. Based on product & service, the RNA analysis market is segmented into reagents/consumables, instruments, software, and servic